SP-A enhances viral clearance and inhibits inflammation after pulmonary adenoviral infection

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 277, Issue 3 21-3, 1999, Pages

  Harrod, Kevin S ^a   Trapnell, Bruce C ^a   Otake, Kazuhisa ^a   Korfhagen, Thomas R ^a   Whitsett, Jeffrey A ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Alveolar macrophages; Collectins; Lung epithelium; Surfactant protein A

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; SURFACTANT PROTEIN A; TUMOR NECROSIS FACTOR ALPHA;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; HOST RESISTANCE; INFLAMMATORY CELL; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS MACROPHAGE; LUNG INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0032887227     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.1999.277.3.l580     Document Type: Article

References (34)

1. Allen, R. D., T. A. Staley, and C. L. Sidman. Differential cytokine expression in acute and chronic murine graft-versus-host-disease. Eur. J. Immunol. 23: 333-337, 1993.
2. Baughman, R. P., R. I. Sternberg, W. Hull, J. A. Buchsbaum, and J. Whitsett. Decreased surfactant protein A in patients with bacterial pneumonia. Am. Rev. Respir. Dis. 147: 653-1357, 1993.
3. Benne, C. A., B. Benaissa-Trouw, J. A. van Strijp, C. A. Kraaijeveld, and J. F. van Iwaarden. Surfactant protein A, but not surfactant protein D, is an opsonin for influenza A virus phagocytosis by rat alveolar macrophages. Eur. J. Immunol. 27: 886-890, 1997.
4. Benne, C. A., C. A. Kraaijeveld, J. A. van Strijp, E. Brouwer, M. Harmsen, J. Verhoef, L. M. van Golde, and J. F. van Iwaarden, Interactions of surfactant protein A with influenza A viruses: binding and neutralization. J. Infect. Dis. 171: 335-341, 1995.
5. Borron, P., F. X. McCormack, B. M. Elhalwagi, Z. C. Chroneos, J. F. Lewis, S. Zhu, J. R. Wright, V. L. Shepherd, F. Possmayer, K. Inchley, and L. J. Fraher. Surfactant protein A inhibits T cell proliferation via its collagen-like tail and a 210-kDa receptor. Am. J. Physiol. 275 (Lung Cell. Mol. Physiol. 19): L679-L686, 1998.
6. Dai, Y., E. M. Schwarz, D. Gu, W. W. Zhang, N. Sarvetnick, and I. M. Verma. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression. Proc. Natl.Acad. Sci. USA 92: 1401-1405, 1995.
7. Gregory, T. J., W. J. Longmore, M. A. Moxley, J. A. Whitsett, C. R. Reed, A. A. Fowler III, L. D. Hudson, R. J. Maunder, C. Crim, and T. M. Hyers. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J. Clin. Invest. 88: 1976-1981, 1991.
8. Haagsman, H. P., S. Hawgood, T. Sargeant, D. Buckley, R. T. White, K. Drickamer, and B. J. Benson. The major lung surfactant protein, SP 28-36, is a calcium-dependent, carbohydrate-binding protein. J. Biol. Chem. 262: 13877-13880, 1987.
9. Harrod, K. S., A. D. Mounday, B. R. Stripp, and J. A. Whitsett. Clara cell secretory protein decreases lung inflammation after acute virus infection. Am. J. Physiol. 275 (Lung Cell. Mol. Physiol. 19): L924-L930, 1998.
10. Ikegami, M., T. R. Korfhagen, M. D. Bruno, J. A. Whitsett, and A. H. Jobe. Surfactant metabolism in surfactant protein A-deficient mice. Am. J. Physiol. 272 (Lung Cell. Mol. Physiol. 16): L479-L485, 1997.
11. Korfagen, T. R., M. D. Bruno, G. F. Ross, K. M. Heulsman, M. Ikegami, A. H. Jobe, S. E. Wert, B. R. Stripp, R. E. Morris, S. W. Glasser, C. J. Bachurski, H. S. Iwamoto, and J. A. Whitsett. Altered surfactant function and structure in SP-A gene targeted mice. Proc. Natl. Acad. Sci. USA 93: 9594-9599, 1996.
12. Kuzmin, A. I., M. J. Finegold, and R. C. Eisensmith. Macrophage depletion increases the safety, efficacy and persistence of adenovirus-mediated gene transfer in vivo. Gene Ther. 4: 309-316, 1997. 13
13. Leopold, P. L., B. Ferris, I. Grinberg, S. Worgall, N. R. Hackett, and R. G. Crystal. Fluorescent virions: dynamic tracking of the pathway of adenoviral gene transfer vectors in living cells. Hum. Gene Ther. 9: 367-378, 1998.
14. LeVine, A. M., M. D. Bruno, K. M. Huelsman, G. F. Ross, J. A. Whitsett, and T. R. Korfhagen. Surfactant protein A-deficient mice are susceptible to group B streptococcal infection. J. Immunol. 158: 4336-4340, 1997.
15. LeVine, A. M., K. E. Kurak, M. D. Bruno, J. M. Stark, J. A. Whitsett, and T. R. Korfhagen. Surfactant protein-A-deficient mice are susceptible to Pseudomonas aeruginosa infection. Am. J. Respir. Cell Mol. Biol. 19: 700-708, 1998.
16. LeVine, A. M., A. Lotze, S. Stanley, C. Stroud, R. O'Donnell, J. Whitsett, and M. M. Pollack. Surfactant content in children with inflammatory lung disease. Crit. Care Med. 24: 1062-1067, 1996.
17. Manz-Keinke, H., H. Plattner, and J. Schlepper-Schafer. Lung surfactant protein A (SP-A) enhances serum-independent phagocytosis of bacteria by alveolar macrophages. Eur. J. Cell Biol. 57: 95-100, 1992.
18. McIntosh, J. C., S. Mervin-Blake, E. Conner, and J. R. Wright. Surfactant protein A protects growing cells and reduces TNF-α activity from LPS-stimulated macrophages. Am. J. Physiol. 271 (Lung Cell. Mol. Physiol. 15): L310-L319, 1996.
19. McNeely, T. B., and J. D. Coonrod. Aggregation and opsonization of type A but not type B Hemophilus influenzae by surfactant protein A. Am. J. Respir. Cell Mol. Biol. 11: 114-122, 1994.
20. Otake, K., D. L. Ennist, K. Harrod, and B. C. Trapnell. Nonspecific inflammation inhibits adenovirus-mediated pulmonary gene transfer and expression independent of specific acquired immune responses. Hum. Gene Ther. 9: 2207-2222, 1998.
21. Pison, U., U. Obertacke, W. Seeger, and S. Hawgood. Surfactant protein A (SP-A) is decreased in acute parenchymal lung injury associated with polytrauma. Eur. J. Clin. Invest. 22: 712-718, 1992.
22. Pison, U., J. R. Wright, and S. Hawgood. Specific binding of surfactant apoprotein SP-A to rat alveolar macrophages. Am. J. Physiol. 262 (Lung Cell. Mol. Physiol. 6): L412-L417, 1992.
23. Sastry, K., and R. A. Ezekowitz. Collectins: pattern recognition molecules involved in first line host defense. Curr. Opin. Immunol. 5: 59-66, 1993 [Corrigenda. Curr. Opin. Immunol. 5: August 1993, p. 566.]
24. Sastry, K., and R. A. Ezekowitz. Collectins: pattern recognition molecules involved in first line host defense. Curr. Opin. Immunol. 5: 59-66, 1993 [Corrigenda. Curr. Opin. Immunol. 5: August 1993, p. 566.]
25. Van Iwaarden, F., B. Welmers, J. Verhoef, H. P. Haagsman, and L. M. van Golde. Pulmonary surfactant protein A enhances the host-defense mechanism of rat alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 2: 91-98, 1990.
26. Van Iwaarden, J. F., J. A. G. van Strijp, M. J. M. Ebskamp, A. C. Welmers, J. Verhoef, and L. M. G. van Golde. Surfactant protein A is an opsonin in phagocytosis of herpes simplex virus type I by rat alveolar macrophages. Am. J. Physiol. 261 (Lung Cell Mol. Physiol. 5): L204-L209, 1991.
27. Van Iwaarden, J. F., J. A. van Strijp, H. Visser, H. P. Haagsman, J. Verhoef, and L. M. van Golde. Binding of surfactant protein A (SP-A) to herpes simplex virus type 1-infected cells is mediated by the carbohydrate moiety of SP-A. J. Biol. Chem. 267: 25039-25043, 1992.
28. Wolff, G., S. Worgall, N. van Rooijen, W. R. Song, B. G. Harvey, and R. G. Crystal. Enhancement of in vivo adenovirus-mediated gene transfer and expression by prior depletion of tissue macrophages in the target organ. J. Virol. 71: 624-629, 1997.
29. Worgall, S., P. L. Leopold, G. Wolff, B. Ferris, N. Van Roijen, and R. G. Crystal. Role of alveolar macrophages in rapid elimination of adenovirus vectors administered to the epithelial surface of the respiratory tract. Hum. Gene Ther. 8: 1675-1684, 1997.
30. Wright, J. R., J. D. Borchelt, and S. Hawgood. Lung surfactant apoprotein SP-A (26-36 kDa) binds with high affinity to isolated alveolar type II cells. Proc. Natl. Acad. Sci. USA 86: 5410-5414, 1989.
31. Wright, J. R., and D. C. Youmans. Pulmonary surfactant protein A stimulates chemotaxis of alveolar macrophage. Am. J. Physiol. 264 (Lung Cell. Mol. Physiol. 8): L338-L344, 1993.
32. Yang, Y., Q. Li, H. C. Ertl, and J. M. Wilson. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69: 2004-2015, 1995.
33. Yang, Y., F. A. Nunes, K. Berencsi, E. E. Furth, E. Gonczol, and J. M. Wilson. Cellular immunity to viral antigens limits El-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91: 4407-4411, 1994.
34. Zsengeller, Z. K., S. E. Wert, W. M. Hull, X. Hu, S. Yei, B. C. Trapnell, and J. A. Whitsett. Persistence of replication-deficient adenovirus-mediated gene transfer in lungs of immune-deficient (nu/nu) mice. Hum. Gene Ther. 6: 457-467, 1995.